Chapter 1 What is GARDE?

GARDE is an open-source software platform, funded by several grants from the National Cancer Institute, that enables population-level risk assessment and genetic testing for conditions (e.g., cancer, familial hypercholesterolemia) for which there are guidelines that support genetic testing. GARDE has two main components:

  1. population-level risk assessment algorithms that analyze patient data in the electronic health record (EHR) to identify patients who meet criteria for genetic testing (Figure 1); and
GARDE architecture

Figure 1. GARDE workflow.

  1. an automated chatbot for patient outreach, pretest education, and access to genetic testing (Figure 2).
GARDE architecture

Figure 2. Chatbot example.

GARDE uses an open architecture, external to the EHR, and is integrated with the EHR through standards-based Web services.

All illustrations CC-BY.
All other materials CC-BY unless noted otherwise.